Recently, the National Pharmaceutical Project successfully won the bid for the yuan biotechnology plant source recombinant human serum albumin industrialization base construction project sewage general contracting project.

, the project has a total construction area of about 7 million square meters. At present, the main structure has been capped and is expected to be completed in 2026It was officially put into operation in the second quarter of the year. As an important industrial base in the field of recombinant human serum albumin of plant origin in China, its sewage treatment project is faced with the severe challenges of large daily treatment scale, complex water quality composition (including high concentration of phosphorus ammonia salt, isopropanol, etc.) and high emission standard. With its deep technical accumulation in the field of biopharmaceutical environmental protection, Sinopharm Engineering innovatively adopts a graded treatment mode to achieve precise separation of wastewater with different pollution loads, optimizes energy consumption configuration in real time with an intelligent energy dynamic distribution system, and ensures stable and up-to-standard discharge under water quality fluctuations through an anti-shock load enhancement design.

With advanced, stable and efficient environmental protection technology, the National Pharmaceutical Project will make every effort to ensure the safe and stable large-scale mass production of "rice hematopoiesis" technology of Heyuan Biology, accelerate the replacement process of domestic high-end human serum albumin, help Heyuan Biology to build a green benchmark for zero pollution, low energy consumption and high circulation, and jointly write a new chapter in the high-quality development of biological manufacturing in the Yangtze River Economic Belt.

(Headquarters environmental protection company contribution)